MinervaX
Last updated: May 02, 2024
Founder Per Fischer
Country: Denmark | Funding: $215.5M (+)
Website: http://minervax.com/
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Website: http://minervax.com/
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.